GoodRx Holdings, Inc.GDRXNASDAQ
Loading
Year-over-year research & development expense growth
Percentile
P7
Near historical low
vs 5Y Ago
-0.1x
Contraction
Streak
1 qtr
Consecutive declineDecelerating
| Period | Value |
|---|---|
| Q4 2025 | -6.68% |
| Q3 2025 | 3.60% |
| Q2 2025 | -3.88% |
| Q1 2025 | -1.88% |
| Q4 2024 | 5.31% |
| Q3 2024 | -2.32% |
| Q2 2024 | -0.53% |
| Q1 2024 | -3.17% |
| Q4 2023 | -19.13% |
| Q3 2023 | 26.61% |
| Q2 2023 | -4.93% |
| Q1 2023 | -10.50% |
| Q4 2022 | 2.36% |
| Q3 2022 | 1.46% |
| Q2 2022 | 1.03% |
| Q1 2022 | -0.05% |
| Q4 2021 | -0.04% |
| Q3 2021 | 18.62% |
| Q2 2021 | 13.02% |
| Q1 2021 | 10.46% |
| Q4 2020 | 49.46% |
| Q3 2020 | 32.47% |
| Q2 2020 | 15.85% |
| Q1 2020 | 5.14% |
| Q4 2019 | 25.19% |
| Q3 2019 | 30.80% |
| Q2 2019 | 3.08% |
| Q1 2019 | 0.00% |